drugset / Trial / NCT01566539

Biological Basis of Individual Variation in Social Cooperation

NCT01566539

RandomizedFactorialTriple-blindBasic science

Summary

The project has three overall objectives. The first is to determine whether and how administration of intranasal oxytocin (OT) and intranasal vasopressin (AVP) influence cooperative decision-making and neural responses to cooperative and un-cooperative social interactions. The second is to determine whether and how intranasal vasopressin influences subjective evaluations of and neural responses to same and opposite-sex face stimuli and to determine if any of these effects persist beyond the period of AVP exposure. The third objective is to determine if intranasal OT influences empathy-related behavior and associated brain activity.

Timeline

Start
2008-04
Primary completion
2016-11
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Lorazepam Small molecule 1 mg Oral
Subject Oxytocin Peptide 24 iu Intranasal
Subject Vasopressin Peptide 20 iu Intranasal
Subject Vasopressin Peptide 40 iu Intranasal

Indications

No indication recorded.